Pyrazolam | The JHI

Back

Pyrazolam

Found in:  

Fentanyl, BZD

Type/Reason added:  

Short Acting DBZD

Relative Potency:  

N/A

Overview

The Effects

Treatment Options

Supportive Care:

Acute benzodiazepine intoxication primarily relies on supportive care for management. This may include definitive airway management via endotracheal intubation.

Antidote:

While the antidote flumazenil can effectively reverse benzodiazepine-mediated sedation, its use in acute benzodiazepine intoxication is not recommended due to the potential risks that may outweigh benefits as it can precipitate acute withdrawal syndromes, lower seizure threshold, and cause cardiac dysrhythmias. In the context of managing acute benzodiazepine intoxication in non-habituated patients, the administration of flumazenil should be undertaken with caution and a careful risk versus benefit to the patients.

Pharmacokinetics and Dynamics

Metabolism:

Pyrazolam is metabolized in the liver, primarily via CYP enzymes, though it produces little to no active metabolites. This means its duration of action is relatively predictable, with a half-life estimated to be around 10 to 12 hours. Because it does not accumulate significantly in the body, it has a more controlled effect compared to longer-acting benzodiazepines.

Drug-Drug Interactions:

Like all benzodiazepines, pyrazolam has dangerous interactions with central nervous system depressants such as alcohol, opioids, and other sedatives, increasing the risk of respiratory depression and overdose. It may also interact with CYP3A4 inhibitors (such as grapefruit juice or certain medications), which can prolong its effects.